Last Price
0.281
Today's Change
-0.052 (15.61%)
Day's Change
0.24 - 0.285
Trading Volume
4,649,266
Market Cap
4 Million
Shares Outstanding
14 Million
Avg Volume
5,871,481
Avg Price (50 Days)
0.44
Avg Price (200 Days)
7.75
PE Ratio
-0.19
EPS
-1.47
Earnings Announcement
27-Nov-2024
Previous Close
0.33
Open
0.27
Day's Range
0.2401 - 0.285
Year Range
0.207 - 13.558
Trading Volume
4,650,566
1 Day Change
-15.58%
5 Day Change
25.70%
1 Month Change
-16.28%
3 Month Change
-84.63%
6 Month Change
-97.53%
Ytd Change
-97.42%
1 Year Change
-97.41%
3 Year Change
-97.12%
5 Year Change
-97.19%
10 Year Change
-97.19%
Max Change
-97.19%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.